Jeffrey Walch
Stock Analyst at Bernstein
(2.49)
# 3,053
Out of 5,162 analysts
41
Total ratings
80%
Success rate
4.1%
Average return
Main Sectors:
Stocks Rated by Jeffrey Walch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMMT Summit Therapeutics | Downgraded: Sell | $12 → $8.3 | $10.50 | -20.95% | 10 | Nov 18, 2026 | |
| BNTX BioNTech SE | Reiterated: Hold | $96 | $83.26 | +15.30% | 5 | Nov 6, 2026 | |
| RVMD Revolution Medicines | Reiterated: Hold | $179 | $159.82 | +12.00% | 6 | Nov 4, 2026 | |
| NBIX Neurocrine Biosciences | Reiterated: Buy | $218 | $162.86 | +33.86% | 5 | Nov 3, 2026 | |
| INCY Incyte | Reiterated: Hold | $104 → $108 | $117.80 | -8.32% | 4 | Nov 2, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Hold | $812 | $945.53 | -14.12% | 1 | Nov 2, 2026 | |
| ALNY Alnylam Pharmaceuticals | Downgraded: Hold | $376 → $199 | $149.40 | +33.20% | 4 | Oct 30, 2026 | |
| BIIB Biogen | Reiterated: Buy | $236 | $251.41 | -6.13% | 1 | Oct 19, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Hold | $229 | $247.77 | -7.58% | 3 | Sep 25, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $608 | $536.45 | +13.34% | 2 | Sep 25, 2026 |
Summit Therapeutics
Nov 18, 2026
Downgraded: Sell
Price Target: $12 → $8.3
Current: $10.50
Upside: -20.95%
BioNTech SE
Nov 6, 2026
Reiterated: Hold
Price Target: $96
Current: $83.26
Upside: +15.30%
Revolution Medicines
Nov 4, 2026
Reiterated: Hold
Price Target: $179
Current: $159.82
Upside: +12.00%
Neurocrine Biosciences
Nov 3, 2026
Reiterated: Buy
Price Target: $218
Current: $162.86
Upside: +33.86%
Incyte
Nov 2, 2026
Reiterated: Hold
Price Target: $104 → $108
Current: $117.80
Upside: -8.32%
Regeneron Pharmaceuticals
Nov 2, 2026
Reiterated: Hold
Price Target: $812
Current: $945.53
Upside: -14.12%
Alnylam Pharmaceuticals
Oct 30, 2026
Downgraded: Hold
Price Target: $376 → $199
Current: $149.40
Upside: +33.20%
Biogen
Oct 19, 2026
Reiterated: Buy
Price Target: $236
Current: $251.41
Upside: -6.13%
Jazz Pharmaceuticals
Sep 25, 2026
Reiterated: Hold
Price Target: $229
Current: $247.77
Upside: -7.58%
Vertex Pharmaceuticals
Sep 25, 2026
Reiterated: Buy
Price Target: $608
Current: $536.45
Upside: +13.34%